Pacific Biosciences Of California | PACB - Debt


Pacific Biosciences Of California reported $892.24M in Debt for its fiscal quarter ending in December of 2023.





Debt Change Date
Agilent USD 3.35B 0 Dec/2025
Bruker USD 2.04B 34.4M Dec/2025
Danaher USD 18.48B 66M Mar/2026
General Electric Aerospace USD 20.28B 217M Mar/2026
Illumina USD 2.55B 23M Dec/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quidel USD 2.83B 9.9M Dec/2025
Revvity USD 3.4B 29.2M Dec/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Standard Biotools USD 27.39M 1.23M Sep/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Waters USD 1.49B 4.92M Dec/2025